Kasey J. Leger

2.5k total citations · 1 hit paper
44 papers, 1.7k citations indexed

About

Kasey J. Leger is a scholar working on Cardiology and Cardiovascular Medicine, Oncology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Kasey J. Leger has authored 44 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Cardiology and Cardiovascular Medicine, 19 papers in Oncology and 11 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Kasey J. Leger's work include Chemotherapy-induced cardiotoxicity and mitigation (19 papers), Acute Lymphoblastic Leukemia research (11 papers) and CAR-T cell therapy research (10 papers). Kasey J. Leger is often cited by papers focused on Chemotherapy-induced cardiotoxicity and mitigation (19 papers), Acute Lymphoblastic Leukemia research (11 papers) and CAR-T cell therapy research (10 papers). Kasey J. Leger collaborates with scholars based in United States, Canada and France. Kasey J. Leger's co-authors include Corinne Summers, Julie R. Park, Michael C. Jensen, Olivia Finney, Colleen Annesley, Hannah Brakke, Assaf P. Oron, Rebecca Gardner, Christopher Brown and Stephanie Mgebroff and has published in prestigious journals such as Circulation, Journal of Clinical Oncology and Blood.

In The Last Decade

Kasey J. Leger

43 papers receiving 1.7k citations

Hit Papers

Intent-to-treat leukemia ... 2017 2026 2020 2023 2017 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Intent-to-treat leukemia remission by CD19 CAR T cells of defined formulation and dose in children and young adults
    2017 787 citations Rebecca Gardner, Olivia Finney et al. Blood profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kasey J. Leger United States 17 1.2k 363 358 337 313 44 1.7k
Olalekan O. Oluwole United States 25 2.1k 1.7× 604 1.7× 46 0.1× 428 1.3× 393 1.3× 154 2.4k
Elena Mead United States 10 2.1k 1.8× 556 1.5× 16 0.0× 597 1.8× 558 1.8× 25 2.4k
Jenna Voutsinas United States 17 1.3k 1.0× 392 1.1× 14 0.0× 271 0.8× 218 0.7× 78 1.6k
Tahsin Özpolat United States 7 850 0.7× 193 0.5× 28 0.1× 210 0.6× 306 1.0× 25 1.1k
Jean Lemoine France 10 540 0.4× 205 0.6× 35 0.1× 61 0.2× 119 0.4× 26 1.1k
Binod Dhakal United States 24 852 0.7× 792 2.2× 38 0.1× 86 0.3× 58 0.2× 163 1.9k
Jun Deng China 15 340 0.3× 247 0.7× 32 0.1× 87 0.3× 77 0.2× 37 714
Lynn O’Donnell United States 12 322 0.3× 187 0.5× 57 0.2× 62 0.2× 76 0.2× 30 788
Zhiyang Zhou China 22 469 0.4× 308 0.8× 36 0.1× 38 0.1× 230 0.7× 80 1.3k
Gerhard Hawa Austria 16 249 0.2× 423 1.2× 127 0.4× 91 0.3× 78 0.2× 32 1.0k

Countries citing papers authored by Kasey J. Leger

Since Specialization
Citations

This map shows the geographic impact of Kasey J. Leger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kasey J. Leger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kasey J. Leger more than expected).

Fields of papers citing papers by Kasey J. Leger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kasey J. Leger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kasey J. Leger. The network helps show where Kasey J. Leger may publish in the future.

Co-authorship network of co-authors of Kasey J. Leger

This figure shows the co-authorship network connecting the top 25 collaborators of Kasey J. Leger. A scholar is included among the top collaborators of Kasey J. Leger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kasey J. Leger. Kasey J. Leger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ryan, Thomas D., James E. Bates, Karen E. Kinahan, et al.. (2025). Cardiovascular Toxicity in Patients Treated for Childhood Cancer: A Scientific Statement From the American Heart Association. Circulation. 151(15). e926–e943. 6 indexed citations
2.
Li, Amanda M., Catherine Aftandilian, Susan I. Colace, et al.. (2024). A Retrospective Study of Inotuzumab Ozogamicin in Individuals with Down Syndrome and B-Cell Acute Lymphoblastic Leukemia. Blood. 144(Supplement 1). 4204–4204.
3.
Sachdeva, Ritu, Kayla Stratton, Saro H. Armenian, et al.. (2024). Utility of apical four‐chamber longitudinal strain in the assessment of childhood cancer survivors: A multicenter study. Echocardiography. 41(2). e15766–e15766. 1 indexed citations
4.
Leger, Kasey J., Michael J. Absalon, Biniyam G. Demissei, et al.. (2024). Cardiotoxicity of CPX-351 in children and adolescents with relapsed AML: a Children's Oncology Group report. Frontiers in Cardiovascular Medicine. 11. 1347547–1347547. 2 indexed citations
5.
Leger, Kasey J., et al.. (2023). Lack of benefit from premedication for pegylated asparaginase during pediatric acute lymphoblastic leukemia/lymphoma therapy: A side‐by‐side comparison. Pediatric Blood & Cancer. 71(1). e30716–e30716. 1 indexed citations
6.
Summers, Corinne, Karen M. Chisholm, Sandra D. Bohling, et al.. (2023). Plasticity of lineage switch in B-ALL allows for successful rechallenge with CD19-directed immunotherapy. Blood Advances. 7(12). 2825–2830. 4 indexed citations
7.
Narayan, Hari K., Victor Wong, D.Y.S. Kuo, et al.. (2022). Cardiovascular toxicities with pediatric tyrosine kinase inhibitor therapy: An analysis of adverse events reported to the Food and Drug Administration. Pediatric Blood & Cancer. 70(2). e30059–e30059. 4 indexed citations
8.
Harker‐Murray, Paul, Christine Mauz‐Körholz, Thierry Leblanc, et al.. (2022). Nivolumab, Brentuximab Vedotin, +/- Bendamustine For R/R Hodgkin Lymphoma in Children, Adolescents, and Young Adults. Blood. 141(17). 2075–2084. 17 indexed citations
9.
Sachdeva, Ritu, Kayla Stratton, Saro H. Armenian, et al.. (2021). Challenges associated with retrospective analysis of left ventricular function using clinical echocardiograms from a multicenter research study. Echocardiography. 38(2). 296–303. 4 indexed citations
10.
Narayan, Hari K., Kelly Getz, & Kasey J. Leger. (2021). Minimizing cardiac toxicity in children with acute myeloid leukemia. Hematology. 2021(1). 368–375. 3 indexed citations
11.
12.
Chow, Eric J., Kasey J. Leger, Neel S. Bhatt, et al.. (2019). Paediatric cardio-oncology: epidemiology, screening, prevention, and treatment. Cardiovascular Research. 115(5). 922–934. 75 indexed citations
13.
Leger, Kasey J., K. Scott Baker, Kara L. Cushing‐Haugen, et al.. (2018). Lifestyle factors and subsequent ischemic heart disease risk after hematopoietic cell transplantation. Cancer. 124(7). 1507–1515. 20 indexed citations
14.
Chapman, Teresa, et al.. (2018). Perforated jejunitis in a child with acute lymphoblastic leukemia treated with pegaspargase. Radiology Case Reports. 13(3). 568–572. 3 indexed citations
15.
16.
Leger, Kasey J., et al.. (2017). Circulating microRNAs: Potential Markers of Cardiotoxicity in Children and Young Adults Treated With Anthracycline Chemotherapy. Journal of the American Heart Association. 6(4). 65 indexed citations
17.
Leger, Kasey J., Russell Migita, Joe C. Rutledge, et al.. (2017). Improving Time to Antibiotics for Pediatric Oncology Patients With Suspected Infections. Pediatric Emergency Care. 34(1). 47–52. 14 indexed citations
18.
Leger, Kasey J., Kara L. Cushing‐Haugen, John A. Hansen, et al.. (2016). Clinical and Genetic Determinants of Cardiomyopathy Risk among Hematopoietic Cell Transplantation Survivors. Biology of Blood and Marrow Transplantation. 22(6). 1094–1101. 33 indexed citations
19.
20.
Lipshultz, Steven E., Vivian I. Franco, Sanjeev Aggarwal, et al.. (2014). Managing Chemotherapy-Related Cardiotoxicity in Survivors of Childhood Cancers. Pediatric Drugs. 16(5). 373–389. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Olalekan O. Oluwole Breakdown of academic impact, for papers by Elena Mead Breakdown of academic impact, for papers by Jenna Voutsinas Breakdown of academic impact, for papers by Tahsin Özpolat Breakdown of academic impact, for papers by Jean Lemoine Breakdown of academic impact, for papers by Binod Dhakal Breakdown of academic impact, for papers by Jun Deng Breakdown of academic impact, for papers by Lynn O’Donnell Breakdown of academic impact, for papers by Zhiyang Zhou Breakdown of academic impact, for papers by Gerhard Hawa
Rankless by CCL
2026